MetaCap

Who Owns Veraxa Biotech Stock?

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04+0.01 (+0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
1.46%
Institutional holders
11
  • Institutions 1.5%
  • Insiders 69.9%
  • Public and other 28.6%

Who owns Veraxa Biotech stock?

Institutional investors own about 1.5% of Veraxa Biotech's shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 69.95% of VRXA.

The largest institutional holders are Yorkville Advisors Global, LP (0.74%), Geode Capital Management, LLC (0.06%) and UBS Group AG (0.05%). Together, the top 8 institutions control 0.9% of shares outstanding. In their latest filings, 5 of the top 8 institutions increased their VRXA positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of VRXA

Veraxa Biotech top institutional holders
InstitutionShares% HeldChange
Yorkville Advisors Global, LP1.04M0.74%+100.0%
Geode Capital Management, LLC91.53K0.06%-23.6%
UBS Group AG72.14K0.05%-54.1%
Cantor Fitzgerald, L.P.70.00K0.05%+100.0%
Millennium Management Llc30.57K0.02%+100.0%
Marex Group Ltd.22.01K0.02%+100.0%
Wolverine Asset Management, LLC1.75K0.00%0.0%
JPMORGAN CHASE & CO5140.00%+29.8%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of VRXA

Veraxa Biotech top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund57.82K0.04%
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF33.71K0.02%

Frequently asked questions

Who is the largest shareholder of Veraxa Biotech?

Yorkville Advisors Global, LP is the largest institutional shareholder of VRXA, owning 0.74% of shares outstanding (1.04M shares) as of its latest 13F filing.

What percentage of Veraxa Biotech is owned by institutions?

Institutions own about 1.5% of VRXA shares and 4.9% of the public float.

How much of Veraxa Biotech do insiders own?

Insiders, such as officers and directors, own about 69.95% of VRXA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related